期刊文献+

2型糖尿病与子宫内膜癌关系的回顾性分析 被引量:3

Retrospective analysis of the relation between diabetes mellitus and endometrial cancer
下载PDF
导出
摘要 目的:探讨2型糖尿病对子宫内膜癌的影响。方法:回顾性分析旺旺医院2005年至2010年间25例子宫内膜癌病例资料,分析合并有糖尿病的子宫内膜癌患者在肿瘤患病率、分期、预后等方面与未合并糖尿病的患者间的差异。结果:合并糖尿病的子宫内膜癌患者诊断时更多属于Ⅲ期;合并糖尿病的子宫内膜癌患者中体质量指数多为超重,同时血糖控制不佳;合并糖尿病的肿瘤患者的3年生存率明显短于未合并糖尿病患者。结论:糖尿病人群的子宫内膜癌的患病率较高,且肿瘤分期晚,预后不良。 Objective: To Investigate the influence of Type 2 diabetes on endometrial cancer stage, and overall survial rate among endometrial cancer patients. Methods: Clinical data for 25 patients with endometrial cancer were retrospectively analyzed. The prevalence rate, cancer stage, and overall survival rate were compared between endometrial cancer patients complicated with Type 2 diabetes and those without Type 2 diabetes. Results: More cancer patients with diabetes were found to at Stage Ill by the time of cancer diagnosis. The survival rate at 3 year in endometrial cancer patients with diabetes was significantly reduced compared with those patients without diabetes. More cancer patients with diabetes had body mass index 〉26 kg/m2 and higher blood sugar levels than those without diabetes. Conclusion: The prevalence of endometrial cancer in patieats with diabetes is higher than in those without diabetes, and is associated with a later stage of cancer and a poor prognosis.
出处 《国际病理科学与临床杂志》 CAS 2012年第1期27-29,共3页 Journal of International Pathology and Clinical Medicine
关键词 糖尿病 子宫内膜癌 预后 diabetes mellitus endometrial cancer prognosis
  • 相关文献

参考文献2

二级参考文献23

  • 1高静 ,项永兵 ,徐望红 ,邵常霞 ,阮志贤 ,程家蓉 ,SHU Xiao-ou ,高玉堂 .绿茶与子宫内膜癌关系的病例对照研究[J].中华流行病学杂志,2005,26(5):323-327. 被引量:7
  • 2[1]Jemal A,Thomas A,Murray T,et al.Cancer statistics,2002[J].CA Cancer J Clin,2002,52(1):23-47.
  • 3[2]Sang ML,Jong RH,Tae SJ,et al.A case of Cushing′s syndrome presenting as endometrial hyperplasia[J].The Korean Journal of Internal Medicine,2008,23(1):49-52.
  • 4[3]The Writing Group for the PEPl Trial.Effects of hormone replacement therapy on endometrial histology in postmenopausal women.The Postmenopausal Estrogen/Progestin Interventions(PEPI)Trial[J].JAMA,1996,275(5):370-375.
  • 5[4]Yamazawa K,Miyazawa Y,Suzuki M,et al.Tamoxifen and the risk of endometrial cancer in Japanese women with breast cancer[J].Surg Today,2006,36(1):41-46.
  • 6[5]Weiderpass E,Adami HO,Baron JA,et al.Use of oral contraceptives and endometrial cancer risk (Sweden)[J].Cancer Causes Control,1999,10(4):277-284.
  • 7[7]Flemming R,Sathiyathasan S,Jackson A,et al.Endometrioid adenocarcinoma after insertion of a levonorgestrel-releasing intrauterine system[J].J Minim Invasive Gynecol,2008,15(6):771-773.
  • 8[8]Beining RM,Dennis LK,Smith EM,et al.Meta-analysis of intrauterine device and risk of endometrial cancer[J].Ann Epidemiol,2008,18(6):492-499.
  • 9[9]Lindemann K,Vatten LJ,Ellstrm-Engh M,et al.Body mass,diabetes and smoking,and endometrial cancer risk:a follow-up study[J].Br J Cancer,2008,98(9):1582-1585.
  • 10[10]Friberg E,Mantzoros CS,Wolk A.Diabetes and risk of endometrial cancer:a population based prospective cohort study[J].Cancer Epidemiol Biomarkers Prev,2007,16(2):276-280.

共引文献33

同被引文献12

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部